Leiomyosarcoma CT

Jump to navigation Jump to search

Leiomyosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Leiomyosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Leiomyosarcoma CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Leiomyosarcoma CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Leiomyosarcoma CT

CDC on Leiomyosarcoma CT

Leiomyosarcoma CT in the news

Blogs on Leiomyosarcoma CT

Directions to Hospitals Treating Leiomyosarcoma

Risk calculators and risk factors for Leiomyosarcoma CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]

Overview

The CT is useful to detect the number and site of nodules in the lungs, invasion of the mediastinum and pleura, hila lymph nodes as well as spread to any abdominal organ or metastasis to pelvis. It can confirm the location of the sarcoma and show the organs nearby. These are helpful for determining the stage of cancer and in determining whether surgery is a good treatment option. CT scans can also be used to guide biopsy and a biopsy sample is usually removed and looked at under a microscope.

CT Scan

  • The CT scan can be used to assess the metastasis to the lungs and mediastinum and also follow up after surgical removal or recurrence evaluation.[1]
  • Tumors on CT imagings can be seen as hetergenous mass demonstrating low attenuation representing necrosis.
  • Other features include invasion of the mediastinum and pleura and hilar lymphadenopathy.
  • CT of pelvic and abdomen is follow up modality of choice after therapy with surgery and/or chemoradiaton.



References

  1. Rutkowski, Piotr; Ługowska, Iwona (2014). "Follow-up in soft tissue sarcomas". memo - Magazine of European Medical Oncology. 7 (2): 92–96. doi:10.1007/s12254-014-0146-8. ISSN 1865-5041.


Template:WikiDoc Sources